Vir Biotechnology, Inc.

NASDAQ:VIR

10.5 (USD) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Revenue 86.181,580.4721,087.06867.2450.7110.8680.149
Cost of Revenue 2.765146.31965.865301.579148.472100.22962.512
Gross Profit 83.4151,434.1531,021.203-234.334-147.761-99.361-62.363
Gross Profit Ratio 0.9680.9070.939-3.485-207.821-114.471-418.544
Reseach & Development Expenses 589.671474.648448.006302.411148.472100.22962.512
General & Administrative Expenses 00070.93737.59829.13121.693
Selling & Marketing Expenses 0000000
SG&A 174.049161.762160.79370.93737.59829.13121.693
Other Expenses 0-35.325-8.347-9.123-7.38-0.2120.083
Operating Expenses 767.72601.085600.452364.225178.69119.5681.646
Operating Income -684.305833.068276.891-296.98-177.979-118.692-81.497
Operating Income Ratio -7.940.5270.255-4.416-250.322-136.742-546.96
Total Other Income Expenses Net 56.111-78.788129.051-1.6313.452.3280.721
Income Before Tax -628.194754.28549.802-298.611-174.529-116.364-80.776
Income Before Tax Ratio -7.2890.4770.506-4.441-245.47-134.06-542.121
Income Tax Expense -13.077238.44321.2180.0540.154-0.48-10.924
Net Income -615.061515.837528.584-298.665-174.683-115.884-69.852
Net Income Ratio -7.1370.3260.486-4.441-245.686-133.507-468.805
EPS -4.593.894.07-2.51-1.62-1.2-0.72
EPS Diluted -4.593.833.96-2.51-1.62-1.2-0.72
EBITDA -664.854833.068420.751-289.798-173.462-115.936-81.065
EBITDA Ratio -7.7150.5970.26-4.416-250.322-133.567-544.06